We are live on ! Find out more
GENE

Genetic Technologies Ltd.
GENE

Delisted

GENE was delisted on the 16th of October, 2024.

Back to rankings

17 hedge funds and large institutions have $1.65M invested in Genetic Technologies Ltd. in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

31% more funds holding

Funds holding: 13 → 17 (+4)

35% less capital invested

Capital invested by funds: $2.52M → $1.65M (-$875K)

Holders
17
Holders Change
+4
Holders Change %
+30.77%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$110K
2
VKH
Virtu KCG Holdings
New York
+$90K
3
Bank of America
Bank of America
North Carolina
+$63.1K
4
AGM
Alpine Global Management
New York
+$44.2K
5
Citadel Advisors
Citadel Advisors
Florida
+$15.2K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$541K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$91.1K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$42K
4
Simplex Trading
Simplex Trading
Illinois
-$4.53K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$849K +$110K +5,240 +13%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$498K -$91.1K -4,348 -14%
VKH
3
Virtu KCG Holdings
New York
$77K +$90K +4,298 New
Bank of America
4
Bank of America
North Carolina
$54K +$63.1K +3,014 New
SM
5
Sabby Management
Florida
$48K -$541K -25,823 -91%
AGM
6
Alpine Global Management
New York
$38K +$44.2K +2,111 New
AGU
7
Alpine Group USVI
U.S. Virgin Islands
$38K +$44.2K +2,111 New
Citadel Advisors
8
Citadel Advisors
Florida
$23K +$15.2K +726 +131%
UBS Group
9
UBS Group
Switzerland
$10K +$3.27K +156 +38%
AIM
10
Acrospire Investment Management
Illinois
$7K +$7.56K +361 New
CG
11
Cutler Group
California
$4K – – –
LTFS
12
Ladenburg Thalmann Financial Services
Florida
$2K – – –
Morgan Stanley
13
Morgan Stanley
New York
$1K – – –
Bank of New York Mellon
14
Bank of New York Mellon
New York
– -$42K -1,736 Closed
Simplex Trading
15
Simplex Trading
Illinois
– -$4.53K -216 Closed
Deutsche Bank
16
Deutsche Bank
Germany
– +$628 +30 New

GENE Hedge Fund Activity: Q2 2017 in Review

17 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q2 2017, worth a combined $1.65M — down 35% from $2.52M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new GENE positions and 2 closed out — a net gain of 4 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $110K. The largest seller was Sabby Management, cutting an estimated $541K.

  • 17 institutional investors held Genetic Technologies Ltd. (GENE) as of Q2 2017, up from 13 in Q1 2017.
  • Funds reported $1.65M of Genetic Technologies Ltd. stock for Q2 2017, down 35% quarter-over-quarter.
  • 6 funds opened new Genetic Technologies Ltd. positions in Q2 2017 and 2 closed out, a net change of +4 holders.
  • The largest Genetic Technologies Ltd. buyer in Q2 2017 was Renaissance Technologies, an estimated $110K added.
  • The largest Genetic Technologies Ltd. seller in Q2 2017 was Sabby Management, an estimated $541K sold.

Based on aggregated 13F filings for Q2 2017.